Recently, the human epididymis protein 4 (HE4) has proved to be a promising marker for epithelial ovarian cancer with higher specificity and sensitivity than CA125 in distinguishing malignant from benign pelvic masses [18,19]. This evidence concerns the gene WFDC2 and ovarian carcinoma.